Testing effectiveness (Phase 2)Study completedNCT03988335What this trial is testingEvaluate RIST4721 in Palmoplantar Pustulosis (PPP)Who this might be right forPalmoplantar Pustulosis Aristea Therapeutics, Inc. 35
Early research (Phase 1)Study completedNCT03972280What this trial is testingSafety and Pharmacokinetics of Repeat Doses of CSL324 in Subjects With Hidradenitis Suppurativa and Palmoplantar PustulosisWho this might be right forHidradenitis SuppurativaPalmoplantar Pustulosis CSL Behring 39
Large-scale testing (Phase 3)Study completedNCT04061252What this trial is testingKHK4827 in Subjects With Palmoplantar PustulosisWho this might be right forPalmoplantar Pustulosis Kyowa Kirin Co., Ltd. 126
Post-approval studies (Phase 4)Study completedNCT02400749What this trial is testingApremilast in Palmo-Plantar PsoriasisWho this might be right forPalmo-plantar Psoriasis Innovaderm Research Inc. 100
Not applicableNot Yet RecruitingNCT06790940What this trial is testingConstruction of a Psoriasis and Psoriatic Arthritis Diagnostic Model Based on Multidimensional Nail InformationWho this might be right forPsoriasis (PsO)Psoriatic ArthritisPalmoplantar Pustulosis (PPP)+1 more Shanghai Yueyang Integrated Medicine Hospital 310
Testing effectiveness (Phase 2)Study completedNCT03135548What this trial is testingInitial Dosing of BI 655130 in Palmoplantar Pustulosis PatientsWho this might be right forPsoriasis Boehringer Ingelheim 59
Testing effectiveness (Phase 2)Ended earlyNCT01197989What this trial is testingEfficacy Study of TEPSO® Socks in Improving Palmoplantar PustulosisWho this might be right forPustulosis of Palms and Soles Lenzi Egisto S.P.A. 17
Large-scale testing (Phase 3)Study completedNCT05174065What this trial is testingPhase 3, Randomized Study of Apremilast in Japanese Participants With Palmoplantar Pustulosis (PPP)Who this might be right forPalmoplantar Pustulosis Amgen 176
Testing effectiveness (Phase 2)Study completedNCT01845987What this trial is testingThe Efficacy, Safety and Tolerability of CNTO 1959, a Human Anti-IL 23 Monoclonal Antibody in Participants With Palmoplantar PustulosisWho this might be right forPalmoplantaris Pustulosis Janssen Pharmaceutical K.K. 49
Not applicableStudy completedNCT07428915What this trial is testingEvaluating Legit.Health Plus Support for Improving Diagnosis of Generalized Pustular Psoriasis and Other Skin Conditions Among Primary Care Physicians and DermatologistsWho this might be right forPustular Psoriasis (PP)Generalized Pustular Psoriasis (GPP)Eczema Atopic Dermatitis+11 more AI Labs Group S.L 15
Testing effectiveness (Phase 2)Study completedNCT03633396What this trial is testingEvaluate the Efficacy and Safety of Imsidolimab (ANB019) in Adults With Palmoplantar PustulosisWho this might be right forPalmoplantar Pustulosis Vanda Pharmaceuticals 59
Not applicableUnknownNCT01952275What this trial is testingObservational Study of the Genetic Architecture of Neutrophil-Mediated Inflammatory Skin DiseasesWho this might be right forOther Specified Inflammatory Disorders of Skin or Subcutaneous TissuePyoderma GangrenosumErosive Pustular Dermatosis of the Scalp+25 more University of Zurich 600
Testing effectiveness (Phase 2)Study completedNCT04572997What this trial is testingApremilast in Patients With Moderate to Severe Palmoplantar Pustulosis (PPP) (APLANTUS)Who this might be right forPalmoplantar Pustulosis Kristian Reich 21
Not applicableLooking for participantsNCT07270003What this trial is testingA Prospective, Single-arm, Open-label Clinical Trial to Evaluate the Efficacy and Safety of Ivarmacitinib in the Treatment of Palmoplantar PustulosisWho this might be right forPalmoplantar Pustulosis (PPP) Xijing Hospital 60
Testing effectiveness (Phase 2)Study completedNCT04057937What this trial is testingEvaluate the Efficacy and Safety of Apremilast (CC-10004) in Japanese Subjects With Palmoplantar PustulosisWho this might be right forPalmoplantaris Pustulosis Amgen 90